Quantcast

Got Stocks from QualityStocks Ones To Watch

Got Stocks

Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...




Untitled Document

MRI Interventions, Inc. (MRIC)

OTC Bulletin Board-listed MRI Interventions, Inc. is a medical device company. It develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Using a hospital's existing MRI suite, the design of its FDA-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain. MRI Interventions has its headquarters in Irvine, California.

ClearPoint® is an integrated system of hardware components, disposable components, and intuitive, menu-driven software. MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, relating to the ClearPoint® system. Additionally, the company is working with Boston Scientific to incorporate its MRI-safety technologies into Boston Scientific's implantable leads for cardiac and neurological applications.

The ClearPoint® system enables real-time MRI-guided navigation for a broad variety of minimally-invasive neurosurgery procedures. The platform is especially well-suited for facilitating drug delivery directly to brain tumors. The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be used with 1.5T and 3T scanners.

The ClearPoint® system is the only navigation platform designed to allow real-time visualization during minimally-invasive neurosurgical procedures. ClearPoint software works with MRI to assist surgeons in planning a target and trajectory; the SmartFrame® targeting devices enable the MRI-guided alignment and minimally invasive insertion of surgical instruments.

Furthermore, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

Recently, MRI Interventions announced that its ClearPoint® neuro navigation platform will be on exhibit at the 2015 Annual Meeting of the American Association of Neurological Surgeons (AANS) May 4-6, 2015, in Washington, D.C. The company said that Conference attendees are invited to visit the MRI Interventions booth (#708) to learn about the ClearPoint® system's unique capability to enable a broad spectrum of neurosurgical procedures under real-time MRI guidance.

 

 

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue